BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26791845)

  • 21. [Progress in adjuvant therapy for colorectal cancer].
    Kohnoe S; Kakeji Y; Maehara Y
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tolerability of XELOX in postoperative adjuvant chemotherapy for colorectal cancer].
    Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Kawada J; Takagi M; Fukui A; Iwase K; Tanaka Y
    Gan To Kagaku Ryoho; 2014 Jun; 41(6):743-7. PubMed ID: 25129086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How shall we name the chemotherapy administration before and after metastasectomy? How about "M-neoadjuvant" and "M-adjuvant"?
    Abali H; Dişel U; Urün Y; Güllü I; Saif MW
    Ann Surg Oncol; 2010 Jul; 17(7):1970. PubMed ID: 20217255
    [No Abstract]   [Full Text] [Related]  

  • 24. Metastatic colorectal cancer: is surgery necessary?
    Schmidt C
    J Natl Cancer Inst; 2009 Aug; 101(16):1113-5. PubMed ID: 19671774
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems of randomized controlled study on surgical adjuvant chemotherapy for colorectal cancer in Japan].
    Kodaira S
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2461-6. PubMed ID: 8279842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What's new in adjuvant therapy of colorectal cancers?].
    Louvet C
    Ann Chir; 1998; 52(6):487-90. PubMed ID: 9752495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in the treatment of colorectal cancer].
    Maehara Y; Ohno S; Tomisaki S; Kakeji Y; Watanabe A; Baba H; Adachi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):517-28. PubMed ID: 8678508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating rectal cancer: key issues reconsidered.
    Fakih M
    Oncology (Williston Park); 2008 Nov; 22(12):1444-6. PubMed ID: 19322952
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of colorectal cancer in older patients.
    Xiao H; Lichtman SM
    Oncology (Williston Park); 2006 Jun; 20(7):741-50; discussion 750, 755-6. PubMed ID: 16841797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thirty years of rectal cancer research: a brief history.
    Czito BG; Willett CG
    Oncology (Williston Park); 2008 Nov; 22(12):1441-2, 1444. PubMed ID: 19322951
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Are there indications for adjuvant chemotherapy after excision of colorectal cancer?].
    Gérard A
    Pathol Biol (Paris); 1989 Nov; 37(9):990. PubMed ID: 2691974
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX.
    Des Guetz G; Lecaille C; Mariani P; Bennamoun M; Uzzan B; Nicolas P; Boisseau A; Sastre X; Cucherousset J; Lagorce C; Schischmanoff PO; Morere JF
    Anticancer Res; 2010 Oct; 30(10):4297-301. PubMed ID: 21036755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
    Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
    Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
    Kodaira S; Shatari T; Nozawa K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Regional adjuvant chemotherapy in colorectal cancer].
    Shparyk IaV; Bilyns'kyĭ BT
    Klin Khir; 1995; (9-10):41-5. PubMed ID: 8697216
    [No Abstract]   [Full Text] [Related]  

  • 37. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neoadjuvant chemotherapy for advanced colorectal cancer].
    Ohira G; Miyauchi H; Suzuki K; Nishimori T; Tohma T; Narushima K; Matsubara H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1626-8. PubMed ID: 24393870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities].
    Porschen R; Bermann A
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798
    [No Abstract]   [Full Text] [Related]  

  • 40. [Colorectal cancer liver metastases -- neoadjuvant concepts for preoperative down-sizing].
    Golling M; Gog C; Woeste G; Zapletal C; Wullstein C; Bechstein WO
    Zentralbl Chir; 2006 Apr; 131(2):140-7. PubMed ID: 16612781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.